Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06807203 · ClinicalTrials.gov registry record

Motor-voice Assessment in Infants (MAMI)

A clinical trial of Autism Spectrum Disorder and Neurodevelopmental Disorders, sponsored by Ohio State University.

Recruiting
Registry status
46
Enrollment target
1
Study location

NCT06807203: Recruiting study of Autism Spectrum Disorder and Neurodevelopmental Disorders, sponsored by Ohio State University.

NCT06807203 is a study of Autism Spectrum Disorder and Neurodevelopmental Disorders that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 46 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06807203, a study of Autism Spectrum Disorder and Neurodevelopmental Disorders, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
46 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to discover features of normal and disordered motor-voice profiles that are biobehavioral markers of physical disability in infants.. The main questions it aims to answer are: Identify voice factors among infants with newborn-detectable risk. Identify association between individual characteristics (Gestational age at birth, global function, motor-function) and voice factors. Examine unique features of voice production that are present in infants with high-risk for Cerebral Palsy (CP). Participants will be asked to upload a 3-minute videos of their child at term-age, 3.5-, and 9-months of age. At the 3.5-month and 9-month time point parents can choose to attend an optional in-person assessment with their child.

Primary Outcome

A non-invasive medical exam that evaluates an infant's spontaneous movements to identify neurological issues.

Interventions

  • OTHER Behavioral observation

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2025-01-28
Est. Completion 2030-01-28
Ohio State University

552 total trials

What NCT06807203 shows while recruiting

NCT06807203 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (66% lower).

The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Behavioral observation is the first listed.

NCT06807203 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06807203 about?

NCT06807203 is a clinical study titled "Motor-voice Assessment in Infants (MAMI)". The goal of this observational study is to discover features of normal and disordered motor-voice profiles that are biobehavioral markers of physical disability in infants.. The main questions it aims to answer are: Identify voice factors among infants with newborn-detectable risk. Identify associa...

What is the current status of trial NCT06807203?

This trial is currently recruiting. The enrollment target is 46 participants. The study started on 2025-01-28. Estimated completion is 2030-01-28.

What conditions does trial NCT06807203 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Neurodevelopmental Disorders, Pre-Term, Motor Delay, Cerebral Palsy Infantile.

What interventions are being tested in trial NCT06807203?

The interventions under investigation include: Behavioral observation (OTHER).

Who is sponsoring clinical trial NCT06807203?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06807203 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06807203's enrollment target sits among peer trials

46 149th of 224 higher than 76 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06807203, the US trial registry maintained by the National Library of Medicine. NCT06807203 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.